title: Dose-finding study of oral idarubicin and cyclophosphamide in first-line treatment of elderly patients with metastatic breast cancer.
authors.affiliation: Department of Onco-Hematology, Hôpitaux Universitaires de Strasbourg, France. jean-emmanuel.kurtz@chru-strasbourg.fr
authors.forename: J E
authors.initials: JE
authors.lastname: Kurtz
authors.forename: G
authors.initials: G
authors.lastname: Deplanque
authors.forename: C
authors.initials: C
authors.lastname: Borel
authors.forename: C
authors.initials: C
authors.lastname: Mathelin
authors.forename: G
authors.initials: G
authors.lastname: Prévost
authors.forename: G
authors.initials: G
authors.lastname: Poulin
authors.forename: J C
authors.initials: JC
authors.lastname: Barats
authors.forename: J P
authors.initials: JP
authors.lastname: Bergerat
authors.forename: I
authors.initials: I
authors.lastname: Chapelle-Marcillac
authors.forename: M
authors.initials: M
authors.lastname: Bardonnet
authors.forename: P
authors.initials: P
authors.lastname: Dufour
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000009:adverse effects; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D016001:Confidence Intervals; D003520:Cyclophosphamide / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage*; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D011379:Prognosis; D012074:Remission Induction; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D000903:Antibiotics, Antineoplastic; D003520:Cyclophosphamide; D015255:Idarubicin